The Green-top Guideline No. 38 from September 2020 provides comprehensive information on the management of Gestational Trophoblastic Disease (GTD). It covers the presentation, diagnosis, management, treatment, and follow-up of GTD and GTN, as well as advice on future pregnancy outcomes and contraception. The guideline emphasizes the importance of early detection and proper management of molar pregnancies, including the use of suction curettage for removal. It also outlines the recommended follow-up protocols and treatment options for GTN, with a high overall cure rate. Support for women and their families is highlighted throughout the GTD journey, with individualized care and advice provided. Further research recommendations are also included to enhance understanding and treatment of GTD.